Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Anti-Cancer Drugs | journal | 0.936 Q3 | 102 | 136 | 391 | 5235 | 1230 | 383 | 2.81 | 38.49 | 42.08 |  |
| 52 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.935 Q3 | 90 | 105 | 351 | 3181 | 814 | 334 | 2.47 | 30.30 | 33.69 | |
| 53 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.839 Q3 | 65 | 75 | 350 | 2424 | 636 | 334 | 1.81 | 32.32 | 39.87 | |
| 54 | Cancer Genetics and Cytogenetics | journal | 0.838 Q3 | 78 | 0 | 441 | 0 | 793 | 363 | 2.04 | 0.00 | 0.00 | |
| 55 | European Journal of Cancer Prevention | journal | 0.799 Q3 | 88 | 84 | 229 | 3604 | 732 | 224 | 3.17 | 42.90 | 39.68 | |
| 56 | Current Hematologic Malignancy Reports | journal | 0.796 Q3 | 44 | 41 | 97 | 2338 | 217 | 96 | 2.31 | 57.02 | 34.62 | |
| 57 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.756 Q3 | 68 | 93 | 267 | 3431 | 591 | 256 | 2.01 | 36.89 | 40.32 | |
| 58 | Critical Reviews in Oncogenesis | journal | 0.746 Q3 | 57 | 31 | 27 | 2420 | 37 | 22 | 1.43 | 78.06 | 31.34 | |
| 59 | Medical Oncology | journal | 0.701 Q3 | 90 | 545 | 679 | 15251 | 1299 | 667 | 1.87 | 27.98 | 36.16 | |
| 60 | Technology in Cancer Research and Treatment | journal | 0.698 Q3 | 72 | 62 | 187 | 2166 | 439 | 177 | 2.47 | 34.94 | 26.42 | |
| 61 | Oncology Research | journal | 0.677 Q3 | 76 | 36 | 147 | 1019 | 303 | 146 | 2.13 | 28.31 | 31.49 | |
| 62 | Current Problems in Cancer | journal | 0.571 Q3 | 47 | 25 | 73 | 1356 | 80 | 53 | 1.17 | 54.24 | 20.69 | |
| 63 | Oncology | journal | 0.525 Q3 | 83 | 236 | 740 | 3349 | 663 | 508 | 0.86 | 14.19 | 32.61 | |
| 64 | Journal of Experimental Therapeutics and Oncology | journal | 0.435 Q3 | 40 | 26 | 64 | 1153 | 99 | 61 | 1.15 | 44.35 | 28.74 | |
| 65 | Cancer Therapy | journal | 0.184 Q4 | 9 | 2 | 68 | 74 | 32 | 68 | 0.10 | 37.00 | 42.31 | |
| 66 | National Toxicology Program technical report series | journal | 0.180 | 22 | 7 | 23 | 0 | 23 | 23 | 0.90 | 0.00 | 0.00 | |
| 67 | Journal of Cancer Science and Therapy (discontinued) | journal | 0.178 Q4 | 22 | 91 | 96 | 2708 | 35 | 94 | 0.36 | 29.76 | 33.14 | |
| 68 | Annals of Cancer Research and Therapy | journal | 0.132 Q4 | 7 | 13 | 36 | 226 | 7 | 35 | 0.17 | 17.38 | 18.75 | |
| 69 | American Journal of Cancer Research (discontinued) | journal | 64 | 4 | 0 | 250 | 0 | 0 | 0.00 | 62.50 | 42.86 | | |
| 70 | Cancer Immunology Research | journal | 134 | 17 | 23 | 428 | 113 | 22 | 4.62 | 25.18 | 25.71 | | |
| 71 | Cancer journal (Sudbury, Mass.) | journal | 102 | 93 | 260 | 6216 | 1005 | 226 | 4.17 | 66.84 | 42.58 | | |
| 72 | Journal of Analytical Oncology (discontinued) | journal | 8 | 29 | 0 | 756 | 0 | 0 | 0.00 | 26.07 | 40.18 |  | |
| 73 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 12 | 37 | 1470 | 232 | 37 | 4.13 | 122.50 | 42.42 | | |
| 74 | Oncogenesis | journal | 67 | 34 | 0 | 1571 | 0 | 0 | 0.00 | 46.21 | 44.21 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data